CN110773244A - Micro-fluidic chip for high-throughput screening of nano-particles in cross-vascular transport and preparation method thereof - Google Patents
Micro-fluidic chip for high-throughput screening of nano-particles in cross-vascular transport and preparation method thereof Download PDFInfo
- Publication number
- CN110773244A CN110773244A CN201911016382.6A CN201911016382A CN110773244A CN 110773244 A CN110773244 A CN 110773244A CN 201911016382 A CN201911016382 A CN 201911016382A CN 110773244 A CN110773244 A CN 110773244A
- Authority
- CN
- China
- Prior art keywords
- fluid channel
- pdms
- standing
- silicon wafer
- monocrystalline silicon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 61
- 238000013537 high throughput screening Methods 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title abstract description 8
- 239000012530 fluid Substances 0.000 claims abstract description 140
- 239000011521 glass Substances 0.000 claims abstract description 35
- 210000004204 blood vessel Anatomy 0.000 claims abstract description 15
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 66
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 66
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 66
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 claims description 64
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 claims description 64
- 229910021421 monocrystalline silicon Inorganic materials 0.000 claims description 57
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 50
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 50
- 238000010438 heat treatment Methods 0.000 claims description 50
- 229910052710 silicon Inorganic materials 0.000 claims description 50
- 239000010703 silicon Substances 0.000 claims description 50
- 238000005406 washing Methods 0.000 claims description 37
- 238000000034 method Methods 0.000 claims description 35
- 238000004140 cleaning Methods 0.000 claims description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 32
- 239000008367 deionised water Substances 0.000 claims description 31
- 229910021641 deionized water Inorganic materials 0.000 claims description 31
- 239000000203 mixture Substances 0.000 claims description 30
- 229920002120 photoresistant polymer Polymers 0.000 claims description 30
- 238000001035 drying Methods 0.000 claims description 25
- 229910052757 nitrogen Inorganic materials 0.000 claims description 25
- 239000000758 substrate Substances 0.000 claims description 24
- 239000003795 chemical substances by application Substances 0.000 claims description 17
- 238000002156 mixing Methods 0.000 claims description 15
- 238000003756 stirring Methods 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- 238000004026 adhesive bonding Methods 0.000 claims description 10
- 239000011248 coating agent Substances 0.000 claims description 10
- 238000000576 coating method Methods 0.000 claims description 10
- 238000001259 photo etching Methods 0.000 claims description 10
- 238000004528 spin coating Methods 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 238000000465 moulding Methods 0.000 claims description 6
- 238000005086 pumping Methods 0.000 claims description 4
- 239000003814 drug Substances 0.000 abstract description 39
- 229940079593 drug Drugs 0.000 abstract description 14
- 230000000149 penetrating effect Effects 0.000 abstract description 9
- 238000012216 screening Methods 0.000 abstract description 7
- 230000002792 vascular Effects 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 29
- 206010028980 Neoplasm Diseases 0.000 description 14
- 239000000523 sample Substances 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 4
- 230000008595 infiltration Effects 0.000 description 4
- 238000001764 infiltration Methods 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- 210000002469 basement membrane Anatomy 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- -1 polydimethylsiloxane Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000007792 addition Methods 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000009513 drug distribution Methods 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000005459 micromachining Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000006453 vascular barrier function Effects 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502761—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads, for physically stretching molecules
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502707—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the manufacture of the container or its components
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0647—Handling flowable solids, e.g. microscopic beads, cells, particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/10—Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Dispersion Chemistry (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Clinical Laboratory Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Fluid Mechanics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micromachines (AREA)
Abstract
A high-throughput screening microfluidic chip for transporting nanoparticles across blood vessels and a preparation method thereof are provided, the microfluidic chip comprises a fluid channel layer and a glass supporting layer connected with the fluid channel layer, the lower end face of the fluid channel layer is in contact with the upper end face of the glass supporting layer, a fluid channel I and a fluid channel II are arranged in the fluid channel layer, one end of the fluid channel I is provided with a sample inlet, the other end of the fluid channel I is provided with a sample outlet, the middle of the fluid channel I is communicated with the fluid channel II through a gap channel, and one end of the fluid channel II is provided with a seepage outlet. The microfluidic chip can be used for screening drug-loaded nanoparticles suitable for penetrating through the vascular wall, and the screening accuracy is high.
Description
Technical Field
The invention relates to the technical field of applying a micro-fluidic chip technology to biomedical detection and screening, in particular to a micro-fluidic chip for high-throughput screening of nano-particle cross-vascular transport and a preparation method thereof.
Background
Tumors become the first killers threatening human health at present, and high-efficiency antitumor drugs become important requirements of healthy life of people. With the development of nanotechnology in recent years, nanoparticle drug-loaded therapy for tumors has been widely studied. By adopting the nano technology, the water solubility of the drug can be improved, the pharmacokinetic parameters of the drug in vivo can be improved, and the release speed of the drug can be controlled. However, the therapeutic effect is still not satisfactory as far as now. The reason for this is that the tumor microenvironment is different from the normal human environment in physicochemical properties, and is characterized by low oxygen, low pH, high osmotic pressure and high interstitial fluid pressure. It is also because of these characteristics that the drug cannot reach the tumor tissue at a uniform and effective concentration, resulting in insufficient local drug concentration, and this heterogeneous drug distribution is the main reason for the poor therapeutic effect of the drug-loaded nanoparticles. The key to the treatment of tumors is to study how to maximize the nanoparticles' reach to the tumors, so it is necessary to fully understand the nanoparticle transport process in the human body.
The transport of nanoparticles in the human body can be roughly divided into four stages, transport in blood vessels, penetration of the vessel wall into the interstitial space, transport in the interstitial space and entry into tumor cells. Wherein the transport through the vessel wall plays an important role in the whole transport process, and because the tumor vessel wall lacks basement membrane and adhesion protein, so that a plurality of holes appear on the vessel wall, the nano particles can penetrate through the holes. However, researchers have conducted few studies in this regard, and there is still a lack of clear understanding about the physicochemical properties of nanoparticles and the effect of the environment in blood vessels on their efficiency of penetrating the vessel wall. Therefore, the establishment of a device to screen for nanoparticles suitable for penetrating the vessel wall and a suitable vascular environment is a primary task in current tumor therapy research.
Microfluidic technology is an emerging interdisciplinary technology which is rapidly developed in recent years, and micro-machining and micro-operation which are difficult to be completed by a series of conventional methods can be realized by constructing micro-channels on a chip to process or operate micro-fluid. More accurate operation can be provided in the spatial dimension, and the dimension is closer to the actual dimension. Therefore, the microfluidic chip can be used as a platform for simulating the environment in a human body. At present, the research of screening the nano particles suitable for penetrating through the blood vessel wall and the suitable blood vessel environment by utilizing the microfluidic chip is still blank.
Disclosure of Invention
Aiming at the defects in the prior art, the invention provides the microfluidic chip for high-throughput screening of the cross-vascular transport of the nanoparticles and the preparation method thereof.
The scheme is realized by the following technical measures: a high-throughput screening microfluidic chip for transporting nanoparticles across blood vessels is characterized in that: including fluid passage layer and the glass supporting layer of being connected with the fluid passage layer, the lower terminal surface on fluid passage layer contacts with the up end of glass supporting layer, fluid passage I and fluid passage II are provided with in the fluid passage layer, the one end of fluid passage I is provided with the introduction port, the other end of fluid passage I is provided with the outlet, clearance passageway and II intercommunications of fluid passage are passed through to the middle part of fluid passage I, the one end of fluid passage II is provided with the oozing mouth. Medicine carrying nanoparticle solution is from the injection port injection fluid channel I through pressure application device, and when the process clearance passageway, partly medicine carrying nanoparticle solution can flow out from the play appearance mouth through fluid channel I, and another part medicine carrying nanoparticle solution passes through clearance passageway and gets into fluid channel II and flow out from the infiltration mouth, collects the sample solution of infiltration mouth outflow. The medicine carrying nano-particle solution is replaced, the above processes are repeated, the medicine carrying nano-particle content in the sample solution is collected in a contrast manner, and the medicine carrying nano-particles which are more suitable for penetrating through the wall of the tumor vessel can be screened.
The micro-fluidic chip is prepared by adopting a molding method and comprises the following steps:
(1) cleaning a monocrystalline silicon wafer: washing with deionized water, drying with nitrogen after the washing, and standing on a heating table;
(2) gluing: coating positive photoresist on the surface of a monocrystalline silicon wafer, and performing spin coating;
(3) baking: placing the spin-coated monocrystalline silicon wafer on a heating table for standing;
(4) exposure: placing the photoetching mask plate on the surface of the photoresist, and exposing;
(5) and (3) developing: developing the exposed monocrystalline silicon wafer, cleaning the surface of the monocrystalline silicon wafer by using deionized water, and drying by using nitrogen;
(6) post-baking: placing a monocrystalline silicon wafer on a heating table, and standing to completely cure the photoresist on the surface of the silicon wafer to obtain a silicon-based mold;
(7) constructing a micro-fluidic chip: firstly, mixing PDMS and a curing agent according to a volume ratio of 10:1, uniformly stirring, pouring the mixture on a silicon-based mold, removing bubbles, placing the mixture on a heating table, standing the mixture to completely cure the PDMS, and then removing the completely cured PDMS from the silicon-based mold to obtain a PDMS substrate, namely a fluid channel layer of the microfluidic chip;
(8) cleaning the glass negative plate: washing the glass negative film with absolute ethyl alcohol and deionized water in sequence, and then drying the glass negative film with nitrogen;
(9) bonding: putting the PDMS substrate and the glass substrate into a plasma machine for cleaning, after cleaning, attaching the PDMS substrate and the glass substrate and ensuring that no bubbles are left on the attaching surface, and then compacting by using a weight.
Further, the preparation method of the microfluidic chip comprises the following steps:
(1) cleaning a monocrystalline silicon wafer: washing with deionized water, washing with absolute ethyl alcohol, washing with deionized water, drying with nitrogen after washing, and standing on a microcomputer temperature-controlled heating table at 90 deg.C for 15 min;
(2) gluing: coating the positive photoresist on the surface of a monocrystalline silicon wafer, and spin-coating by using a spin coater of a spin coater at the rotation speed of 700r/min for 20 s;
(3) baking: placing the spin-coated monocrystalline silicon wafer on a microcomputer temperature control heating table at 60 ℃ and standing for 15 minutes;
(4) exposure: placing the photoetching mask plate on the surface of the photoresist, and exposing by using an exposure machine;
(5) and (3) developing: developing the exposed monocrystalline silicon wafer by using a developing solution, cleaning the surface of the monocrystalline silicon wafer by using deionized water, and drying by using nitrogen;
(6) post-baking: placing the monocrystalline silicon piece on a microcomputer temperature control heating table at 60 ℃ and standing for 40 minutes to completely cure the photoresist on the surface of the silicon piece to obtain a silicon-based mold;
(7) constructing a micro-fluidic chip: firstly, mixing PDMS and a curing agent according to a volume ratio of 10:1, uniformly stirring, pouring the mixture on a silicon-based mold, removing bubbles by using a vacuum pump, standing the mixture on a microcomputer temperature-controlled heating table at 60 ℃ for half an hour to completely cure the PDMS, and then removing the completely cured PDMS from the silicon-based mold to obtain an upper fluid channel layer of the microfluidic chip;
(8) cleaning the glass negative plate: sequentially washing the glass negative with absolute ethyl alcohol and deionized water, and then drying with nitrogen; the glass substrate is a glass supporting layer of the microfluidic chip;
(9) bonding: and putting the PDMS substrate and the glass substrate into a plasma machine for cleaning, after cleaning, adhering the PDMS substrate and the glass substrate within 1 minute and ensuring that no air bubbles are left on the adhering surface, then compacting by using a heavy object, and bonding for 12 hours to complete the manufacture of the microfluidic chip.
A micro-fluidic chip for high-throughput screening of nanoparticle cross-vascular transport comprises a fluid channel layer and a fluid permeation layer connected with the fluid channel layer, wherein the lower end face of the fluid channel layer is in contact with the upper end face of the fluid permeation layer, a fluid channel is arranged on the fluid channel layer, the fluid channel is arranged on the lower end face of the fluid channel layer, one end of the fluid channel is provided with a sample inlet, and the other end of the fluid channel is provided with a sample outlet; the fluid permeable layer is provided with an seepage port, and the middle part of the fluid channel is communicated with the seepage port through a gap channel. Adopt this technical scheme, medicine carrying nanoparticle solution is put through pressure and is injected into fluid passage from the introduction port, and medicine carrying nanoparticle solution is at the in-process of fluid passage circulation, and partly medicine carrying nanoparticle solution flows out from the exit port, and another part medicine carrying nanoparticle solution can get into the infiltration mouth through clearance passageway, collects the medicine carrying nanoparticle solution in the infiltration mouth. The medicine carrying nano particle solution is replaced, the above processes are repeated, the medicine carrying nano particle content in the solution is collected in a contrast mode, and medicine carrying nano particles more suitable for penetrating through the wall of a tumor vessel can be screened out.
The micro-fluidic chip is prepared by adopting a molding method and comprises the following steps:
(1) cleaning a monocrystalline silicon wafer: washing with deionized water, drying with nitrogen after washing, and standing on a heating table;
(2) gluing: coating positive photoresist on the surface of a monocrystalline silicon wafer, and performing spin coating;
(3) baking: placing the spin-coated monocrystalline silicon wafer on a heating table for standing;
(4) exposure: placing the photoetching mask plate on the surface of the photoresist, and exposing;
(5) and (3) developing: developing the exposed monocrystalline silicon wafer, cleaning the surface of the monocrystalline silicon wafer by using deionized water, and drying by using nitrogen;
(6) post-baking: placing a monocrystalline silicon wafer on a heating table, and standing to completely cure the photoresist on the surface of the silicon wafer to obtain a silicon-based mold;
(7) constructing a micro-fluidic chip: firstly, mixing PDMS and a curing agent according to a volume ratio of 10:1, uniformly stirring, pouring the mixture on a silicon-based mold of a fluid channel layer, removing bubbles, placing the mixture on a heating table, standing the mixture to completely cure the PDMS, and then removing the completely cured PDMS from the silicon-based mold of the fluid channel layer to obtain the fluid channel layer; then mixing PDMS and a curing agent according to the volume ratio of 15:1, uniformly stirring, pouring the mixture on a silicon-based mold of a fluid permeation layer, removing air bubbles, placing the mixture on a heating table for standing, removing the PDMS from the silicon-based mold of the fluid permeation layer when the PDMS is not completely cured, and then quickly closing and clamping the PDMS and a fluid channel layer;
(8) thermal bonding: and placing the oppositely clamped fluid channel layer and the fluid permeation layer on a heating table for standing.
Further, the preparation method of the microfluidic chip comprises the following steps:
(1) washing with deionized water, washing with absolute ethyl alcohol, washing with deionized water, drying with nitrogen after washing, and standing on a microcomputer temperature-controlled heating table at 90 deg.C for 15 min;
(2) gluing: coating the positive photoresist on the surface of a monocrystalline silicon wafer, and spin-coating by using a spin coater of a spin coater at the rotation speed of 700r/min for 20 s;
(3) baking: placing the spin-coated monocrystalline silicon wafer on a microcomputer temperature control heating table at 60 ℃ and standing for 15 minutes;
(4) exposure: placing the photoetching mask plate on the surface of the photoresist, and exposing by using an exposure machine;
(5) and (3) developing: developing the exposed monocrystalline silicon wafer by using a developing solution, cleaning the surface of the monocrystalline silicon wafer by using deionized water, and drying by using nitrogen;
(6) post-baking: placing the monocrystalline silicon piece on a microcomputer temperature control heating table at 60 ℃ and standing for 40 minutes to completely cure the photoresist on the surface of the silicon piece to obtain a silicon-based mold;
(7) constructing a micro-fluidic chip: mixing PDMS and a curing agent according to a volume ratio of 10:1, uniformly stirring, pouring the mixture on a silicon-based mold of a fluid channel layer, removing bubbles by using a vacuum pumping pump, standing the mixture on a microcomputer temperature-control heating table at 60 ℃ for half an hour to completely cure the PDMS, and then removing the completely cured PDMS from the silicon-based mold of the fluid channel layer to obtain an upper layer of the microfluidic chip; then mixing PDMS and a curing agent according to a volume ratio of 15:1, uniformly stirring, pouring onto a silicon-based mold of the fluid permeation layer, removing air bubbles by using a vacuum pump, standing for 30 minutes on a microcomputer temperature control heating table at 60 ℃, removing the PDMS from the silicon-based mold of the fluid permeation layer when the PDMS is not completely cured, and then quickly closing and clamping with the fluid channel layer.
(8) Thermal bonding: and placing the oppositely clamped fluid channel layer and the fluid permeable layer on a microcomputer temperature control heating table at the temperature of 80 ℃ for standing for 10 hours, and finishing the manufacture of the microfluidic chip.
Compared with the prior art, the invention has the following beneficial effects: the microfluidic chip can be used for screening drug-loaded nanoparticles suitable for penetrating through a vascular wall, the screening accuracy is high, the requirement that modern drug-loaded nanoparticles penetrate through vascular barrier medical research can be met, only drug-loaded nanoparticle solution is consumed in the whole screening process, so the process cost of drug screening is low, the preparation process of the microfluidic chip is relatively simple, and the manufacturing cost is low.
Therefore, compared with the prior art, the invention has prominent substantive features and remarkable progress, and the beneficial effects of the implementation are also obvious.
Drawings
FIG. 1 is a schematic diagram of a planar structure of a microfluidic chip for high throughput screening of nanoparticles transported across blood vessels in example 1;
FIG. 2 is a schematic perspective view of a microfluidic chip for high throughput screening of nanoparticles transported across blood vessels in example 1;
FIG. 3 is an enlarged view of portion A of FIG. 2;
fig. 4 is a schematic structural diagram of the microfluidic chip for high-throughput screening of nanoparticles transported across blood vessels in example 2.
In the figure: 1-a sample inlet, 2-a fluid channel I, 3-a sample outlet, 4-a seepage outlet, 5-a gap channel, 6-a fluid channel II, 7-a fluid channel layer, 8-a glass supporting layer, 9-a fluid permeation layer and 10-a fluid channel.
Detailed Description
In order to clearly illustrate the technical features of the present solution, the following explains the present solution by way of specific embodiments and with reference to the accompanying drawings.
Example 1
As shown in fig. 1-3, a microfluidic chip for high-throughput screening of nanoparticle cross-vessel transport is characterized in that: including fluid channel layer 7 and the glass supporting layer 8 of being connected with fluid channel layer 7, the lower terminal surface of fluid channel layer 7 contacts with the up end of glass supporting layer 8, be provided with fluid channel I2 and fluid channel II 6 in the fluid channel layer 7, the one end of fluid channel I2 is provided with introduction port 1, the other end of fluid channel I2 is provided with out appearance mouth 3, the middle part of fluid channel I2 passes through clearance passageway 5 and fluid channel II 6 intercommunication, the one end of fluid channel II 6 is provided with ooze mouth 4. Medicine carrying nanoparticle solution is from introduction port 1 injection fluid channel I2 through pressure application device, and when the process clearance passageway 5, some medicine carrying nanoparticle solution can flow out from outlet port 3 through fluid channel I2, and another part medicine carrying nanoparticle solution passes through clearance passageway 5 and gets into fluid channel II 6 and flow out from oozing port 4, collects the sample solution that oozes out 4 outflow. The medicine carrying nano-particle solution is replaced, the above processes are repeated, the medicine carrying nano-particle content in the sample solution is collected in a contrast manner, and the medicine carrying nano-particles which are more suitable for penetrating through the wall of the tumor vessel can be screened. The size of the gap channel 5 is adapted to the size of the hole in the tumor vessel wall caused by the absence of basement membrane and adhesion proteins. The sample outlet 3 and the seepage outlet 4 can be led out through a conduit.
The micro-fluidic chip is prepared by adopting a molding method, and the specific method comprises the following steps:
(1) cleaning a monocrystalline silicon wafer: washing with deionized water, washing with absolute ethyl alcohol, washing with deionized water, drying with nitrogen after washing, and standing on a microcomputer temperature-controlled heating table at 90 deg.C for 15 min;
(2) gluing: coating the positive photoresist on the surface of a monocrystalline silicon wafer, and spin-coating by using a spin coater of a spin coater at the rotation speed of 700r/min for 20 s;
(3) baking: placing the spin-coated monocrystalline silicon wafer on a microcomputer temperature control heating table at 60 ℃ and standing for 15 minutes;
(4) exposure: placing the photoetching mask plate on the surface of the photoresist, and exposing by using an exposure machine;
(5) and (3) developing: developing the exposed monocrystalline silicon wafer by using a developing solution, cleaning the surface of the monocrystalline silicon wafer by using deionized water, and drying by using nitrogen;
(6) post-baking: placing the monocrystalline silicon piece on a microcomputer temperature control heating table at 60 ℃ and standing for 40 minutes to completely cure the photoresist on the surface of the silicon piece to obtain a silicon-based mold;
(7) constructing a micro-fluidic chip: firstly, mixing PDMS and a curing agent according to a volume ratio of 10:1, uniformly stirring, pouring the mixture on a silicon-based mold, removing bubbles by using a vacuum pump, standing the mixture on a microcomputer temperature-controlled heating table at 60 ℃ for half an hour to completely cure the PDMS, and then removing the completely cured PDMS from the silicon-based mold to obtain an upper fluid channel layer of the microfluidic chip;
(8) cleaning the glass negative plate: sequentially washing the glass negative with absolute ethyl alcohol and deionized water, and then drying with nitrogen; the glass substrate is a glass supporting layer of the microfluidic chip;
(9) bonding: and putting the PDMS substrate and the glass substrate into a plasma machine for cleaning, after cleaning, adhering the PDMS substrate and the glass substrate within 1 minute and ensuring that no air bubbles are left on the adhering surface, then compacting by using a heavy object, and bonding for 12 hours to complete the manufacture of the microfluidic chip.
The PDMS is a polydimethylsiloxane polymer, and has good biocompatibility and optical characteristics. The PDMS and the curing agent adopt American Dow Corning SYLGARD184 silicon rubber.
Example 2
A micro-fluidic chip for high-throughput screening of nanoparticle cross-blood vessel transport comprises a fluid channel layer 7 and a fluid permeation layer 9 connected with the fluid channel layer 7, wherein the lower end face of the fluid channel layer 7 is in contact with the upper end face of the fluid permeation layer 9, a fluid channel 10 is arranged on the fluid channel layer 7, the fluid channel 10 is arranged on the lower end face of the fluid channel layer 7, one end of the fluid channel 10 is provided with a sample inlet 1, and the other end of the fluid channel 10 is provided with a sample outlet 3; the fluid permeable layer 9 is provided with a seepage port 4, and the middle part of the fluid channel 10 is communicated with the seepage port 4 through a gap channel 5. Medicine carrying nanoparticle solution is from introduction port 1 injection fluid channel 10 through pressure application device, and medicine carrying nanoparticle solution is at the in-process of fluid channel 10 circulation, and partly medicine carrying nanoparticle solution flows out from outlet 3, and another part medicine carrying nanoparticle solution can get into oozing port 4 through clearance passageway 5, collects the interior medicine carrying nanoparticle solution of oozing port. The medicine carrying nano particle solution is replaced, the above processes are repeated, the medicine carrying nano particle content in the solution is collected in a contrast mode, and medicine carrying nano particles more suitable for penetrating through the wall of a tumor vessel can be screened out. The size of the gap tunnel 5 can be adapted to the size of the hole in the wall of the tumour vessel caused by the absence of basement membrane and adhesion proteins. The sample outlet 3 and the seepage outlet 4 can be led out through a conduit.
The micro-fluidic chip is prepared by adopting a molding method, and the specific method comprises the following steps:
(1) washing with deionized water, washing with absolute ethyl alcohol, washing with deionized water, drying with nitrogen after washing, and standing on a microcomputer temperature-controlled heating table at 90 deg.C for 15 min;
(2) gluing: coating the positive photoresist on the surface of a monocrystalline silicon wafer, and spin-coating by using a spin coater of a spin coater at the rotation speed of 700r/min for 20 s;
(3) baking: placing the spin-coated monocrystalline silicon wafer on a microcomputer temperature control heating table at 60 ℃ and standing for 15 minutes;
(4) exposure: placing the photoetching mask plate on the surface of the photoresist, and exposing by using an exposure machine;
(5) and (3) developing: developing the exposed monocrystalline silicon wafer by using a developing solution, cleaning the surface of the monocrystalline silicon wafer by using deionized water, and drying by using nitrogen;
(6) post-baking: placing the monocrystalline silicon piece on a microcomputer temperature control heating table at 60 ℃ and standing for 40 minutes to completely cure the photoresist on the surface of the silicon piece to obtain a silicon-based mold;
(7) constructing a micro-fluidic chip: mixing PDMS and a curing agent according to a volume ratio of 10:1, uniformly stirring, pouring the mixture on a silicon-based mold of a fluid channel layer, removing bubbles by using a vacuum pumping pump, standing the mixture on a microcomputer temperature-control heating table at 60 ℃ for half an hour to completely cure the PDMS, and then removing the completely cured PDMS from the silicon-based mold of the fluid channel layer to obtain an upper layer of the microfluidic chip; then mixing PDMS and a curing agent according to a volume ratio of 15:1, uniformly stirring, pouring onto a silicon-based mold of the fluid permeation layer, removing air bubbles by using a vacuum pump, standing for 30 minutes on a microcomputer temperature control heating table at 60 ℃, removing the PDMS from the silicon-based mold of the fluid permeation layer when the PDMS is not completely cured, and then quickly closing and clamping with the fluid channel layer.
(8) Thermal bonding: and placing the oppositely clamped fluid channel layer and the fluid permeable layer on a microcomputer temperature control heating table at the temperature of 80 ℃ for standing for 10 hours, and finishing the manufacture of the microfluidic chip.
The PDMS is a polydimethylsiloxane polymer, and has good biocompatibility and optical characteristics. The PDMS and the curing agent adopt American Dow Corning SYLGARD184 silicon rubber.
The technical features of the present invention that are not described in the present invention can be implemented by or using the prior art, and are not described herein again, of course, the above description is not limited to the present invention, and the present invention is not limited to the above embodiments, and variations, modifications, additions or substitutions that are made by those skilled in the art within the spirit and scope of the present invention should also fall within the protection scope of the present invention.
Claims (8)
1. A high-throughput screening microfluidic chip for transporting nanoparticles across blood vessels is characterized in that: including fluid passage layer and the glass supporting layer of being connected with the fluid passage layer, the lower terminal surface on fluid passage layer contacts with the up end of glass supporting layer, fluid passage I and fluid passage II are provided with in the fluid passage layer, the one end of fluid passage I is provided with the introduction port, the other end of fluid passage I is provided with the outlet, clearance passageway and II intercommunications of fluid passage are passed through to the middle part of fluid passage I, the one end of fluid passage II is provided with the oozing mouth.
2. A method for preparing a microfluidic chip for high throughput screening of nanoparticles transported across blood vessels as claimed in claim 1, wherein the method comprises the following steps: the microfluidic chip is prepared by a molding method.
3. The method for preparing the microfluidic chip for high-throughput screening of nanoparticles transported across blood vessels according to claim 2, which is characterized in that: the method comprises the following steps:
(1) cleaning a monocrystalline silicon wafer: washing with deionized water, drying with nitrogen after the washing, and standing on a heating table;
(2) gluing: coating positive photoresist on the surface of a monocrystalline silicon wafer, and performing spin coating;
(3) baking: placing the spin-coated monocrystalline silicon wafer on a heating table for standing;
(4) exposure: placing the photoetching mask plate on the surface of the photoresist, and exposing;
(5) and (3) developing: developing the exposed monocrystalline silicon wafer, cleaning the surface of the monocrystalline silicon wafer by using deionized water, and drying by using nitrogen;
(6) post-baking: placing a monocrystalline silicon wafer on a heating table, and standing to completely cure the photoresist on the surface of the silicon wafer to obtain a silicon-based mold;
(7) constructing a micro-fluidic chip: firstly, mixing PDMS and a curing agent according to a volume ratio of 10:1, uniformly stirring, pouring the mixture on a silicon-based mold, removing bubbles, placing the mixture on a heating table, standing the mixture to completely cure the PDMS, and then removing the completely cured PDMS from the silicon-based mold to obtain a PDMS substrate, namely a fluid channel layer of the microfluidic chip;
(8) cleaning the glass negative plate: washing the glass negative film with absolute ethyl alcohol and deionized water in sequence, and then drying the glass negative film with nitrogen;
(9) bonding: putting the PDMS substrate and the glass substrate into a plasma machine for cleaning, after cleaning, attaching the PDMS substrate and the glass substrate and ensuring that no bubbles are left on the attaching surface, and then compacting by using a weight.
4. The method for preparing the microfluidic chip for high-throughput screening of nanoparticles transported across blood vessels according to claim 3, wherein the method comprises the following steps: the method comprises the following steps:
(1) cleaning a monocrystalline silicon wafer: washing with deionized water, washing with absolute ethyl alcohol, washing with deionized water, drying with nitrogen after washing, and standing on a microcomputer temperature-controlled heating table at 90 deg.C for 15 min;
(2) gluing: coating the positive photoresist on the surface of a monocrystalline silicon wafer, and spin-coating by using a spin coater of a spin coater at the rotation speed of 700r/min for 20 s;
(3) baking: placing the spin-coated monocrystalline silicon wafer on a microcomputer temperature control heating table at 60 ℃ and standing for 15 minutes;
(4) exposure: placing the photoetching mask plate on the surface of the photoresist, and exposing by using an exposure machine;
(5) and (3) developing: developing the exposed monocrystalline silicon wafer by using a developing solution, cleaning the surface of the monocrystalline silicon wafer by using deionized water, and drying by using nitrogen;
(6) post-baking: placing the monocrystalline silicon piece on a microcomputer temperature control heating table at 60 ℃ and standing for 40 minutes to completely cure the photoresist on the surface of the silicon piece to obtain a silicon-based mold;
(7) constructing a micro-fluidic chip: firstly, mixing PDMS and a curing agent according to a volume ratio of 10:1, uniformly stirring, pouring the mixture on a silicon-based mold, removing bubbles by using a vacuum pump, standing the mixture on a microcomputer temperature-controlled heating table at 60 ℃ for half an hour to completely cure the PDMS, and then removing the completely cured PDMS from the silicon-based mold to obtain an upper fluid channel layer of the microfluidic chip;
(8) cleaning the glass negative plate: sequentially washing the glass negative with absolute ethyl alcohol and deionized water, and then drying with nitrogen;
(9) bonding: and putting the PDMS substrate and the glass substrate into a plasma machine for cleaning, after cleaning, adhering the PDMS substrate and the glass substrate within 1 minute and ensuring that no air bubbles are left on the adhering surface, then compacting by using a heavy object, and bonding for 12 hours to complete the manufacture of the microfluidic chip.
5. A high-throughput screening microfluidic chip for transporting nanoparticles across blood vessels is characterized in that: the device comprises a fluid channel layer and a fluid permeation layer connected with the fluid channel layer, wherein the lower end face of the fluid channel layer is contacted with the upper end face of the fluid permeation layer, a fluid channel is arranged on the fluid channel layer and is arranged on the lower end face of the fluid channel layer, one end of the fluid channel is provided with a sample inlet, and the other end of the fluid channel is provided with a sample outlet; the fluid permeable layer is provided with an seepage port, and the middle part of the fluid channel is communicated with the seepage port through a gap channel.
6. A method for preparing the microfluidic chip for high-throughput screening of nanoparticle cross-vessel transport as claimed in claim 5, which is characterized in that: the microfluidic chip is prepared by a molding method.
7. The method for preparing the microfluidic chip for high-throughput screening of nanoparticle cross-vascular transport according to claim 6, wherein the method comprises the following steps: the method comprises the following steps:
(1) cleaning a monocrystalline silicon wafer: washing with deionized water, drying with nitrogen after washing, and standing on a heating table;
(2) gluing: coating positive photoresist on the surface of a monocrystalline silicon wafer, and performing spin coating;
(3) baking: placing the spin-coated monocrystalline silicon wafer on a heating table for standing;
(4) exposure: placing the photoetching mask plate on the surface of the photoresist, and exposing;
(5) and (3) developing: developing the exposed monocrystalline silicon wafer, cleaning the surface of the monocrystalline silicon wafer by using deionized water, and drying by using nitrogen;
(6) post-baking: placing a monocrystalline silicon wafer on a heating table, and standing to completely cure the photoresist on the surface of the silicon wafer to obtain a silicon-based mold;
(7) constructing a micro-fluidic chip: firstly, mixing PDMS and a curing agent according to a volume ratio of 10:1, uniformly stirring, pouring the mixture on a silicon-based mold of a fluid channel layer, removing bubbles, placing the mixture on a heating table, standing the mixture to completely cure the PDMS, and then removing the completely cured PDMS from the silicon-based mold of the fluid channel layer to obtain the fluid channel layer; then mixing PDMS and a curing agent according to the volume ratio of 15:1, uniformly stirring, pouring the mixture on a silicon-based mold of a fluid permeation layer, removing air bubbles, placing the mixture on a heating table for standing, removing the PDMS from the silicon-based mold of the fluid permeation layer when the PDMS is not completely cured, and then quickly closing and clamping the PDMS and a fluid channel layer;
(8) thermal bonding: and placing the oppositely clamped fluid channel layer and the fluid permeation layer on a heating table for standing.
8. The method for preparing the microfluidic chip for high throughput screening of nanoparticles transported across blood vessels according to claim 7, wherein the method comprises the following steps: the method comprises the following steps:
(1) washing with deionized water, washing with absolute ethyl alcohol, washing with deionized water, drying with nitrogen after washing, and standing on a microcomputer temperature-controlled heating table at 90 deg.C for 15 min;
(2) gluing: coating the positive photoresist on the surface of a monocrystalline silicon wafer, and spin-coating by using a spin coater of a spin coater at the rotation speed of 700r/min for 20 s;
(3) baking: placing the spin-coated monocrystalline silicon wafer on a microcomputer temperature control heating table at 60 ℃ and standing for 15 minutes;
(4) exposure: placing the photoetching mask plate on the surface of the photoresist, and exposing by using an exposure machine;
(5) and (3) developing: developing the exposed monocrystalline silicon wafer by using a developing solution, cleaning the surface of the monocrystalline silicon wafer by using deionized water, and drying by using nitrogen;
(6) post-baking: placing the monocrystalline silicon piece on a microcomputer temperature control heating table at 60 ℃ and standing for 40 minutes to completely cure the photoresist on the surface of the silicon piece to obtain a silicon-based mold;
(7) constructing a micro-fluidic chip: mixing PDMS and a curing agent according to a volume ratio of 10:1, uniformly stirring, pouring the mixture on a silicon-based mold of a fluid channel layer, removing bubbles by using a vacuum pumping pump, standing the mixture on a microcomputer temperature-control heating table at 60 ℃ for half an hour to completely cure the PDMS, and then removing the completely cured PDMS from the silicon-based mold of the fluid channel layer to obtain an upper layer of the microfluidic chip; then mixing PDMS and a curing agent according to a volume ratio of 15:1, uniformly stirring, pouring the mixture on a silicon-based mold of a fluid permeation layer, removing air bubbles by using a vacuum pumping pump, standing the mixture on a microcomputer temperature control heating table at 60 ℃ for 30 minutes, removing the PDMS from the silicon-based mold of the fluid permeation layer when the PDMS is not completely cured, and then quickly closing and clamping the PDMS with a fluid channel layer;
(8) thermal bonding: and placing the oppositely clamped fluid channel layer and the fluid permeable layer on a microcomputer temperature control heating table at the temperature of 80 ℃ for standing for 10 hours, and finishing the manufacture of the microfluidic chip.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911016382.6A CN110773244B (en) | 2019-10-24 | 2019-10-24 | Micro-fluidic chip for high-throughput screening of nano-particles in cross-vascular transport and preparation method thereof |
| KR1020200130419A KR102249533B1 (en) | 2019-10-24 | 2020-10-08 | Microfluidic chip for high-throughput screening of transvascular transport of nanoparticles and method for manufacturing same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911016382.6A CN110773244B (en) | 2019-10-24 | 2019-10-24 | Micro-fluidic chip for high-throughput screening of nano-particles in cross-vascular transport and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN110773244A true CN110773244A (en) | 2020-02-11 |
| CN110773244B CN110773244B (en) | 2020-10-20 |
Family
ID=69387001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911016382.6A Active CN110773244B (en) | 2019-10-24 | 2019-10-24 | Micro-fluidic chip for high-throughput screening of nano-particles in cross-vascular transport and preparation method thereof |
Country Status (2)
| Country | Link |
|---|---|
| KR (1) | KR102249533B1 (en) |
| CN (1) | CN110773244B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115312179A (en) * | 2022-05-27 | 2022-11-08 | 南京欧凯生物科技有限公司 | Single cell screening method for colorectal cancer antibody discovery |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114107056B (en) * | 2021-10-27 | 2023-08-08 | 中国科学院大学 | In-vitro blood vessel-like tissue model with fluid environment and application thereof |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN202356108U (en) * | 2011-12-09 | 2012-08-01 | 东南大学 | Micro-current control device for high-throughput separation of nano-grade particles |
| CN105925480A (en) * | 2016-05-12 | 2016-09-07 | 大连理工大学 | Micro-fluidic chip for high-throughput screening of blood brain barrier drug permeability and preparation method of micro-fluidic chip |
| CN107523481A (en) * | 2017-08-17 | 2017-12-29 | 北京旌准医疗科技有限公司 | A kind of micro-nano biomone screening installation based on micro-fluidic chip |
| CN108499619A (en) * | 2018-03-09 | 2018-09-07 | 复旦大学 | A kind of integrated micro-fluidic filtrating chip of film and its preparation method and application |
| US20180304264A1 (en) * | 2012-10-03 | 2018-10-25 | The Government Of The United States Of America, As Represented By The Secretary Of The Navy | Laser Particle Separation and Characterization with Angled Laser Light to Maximize Residence Time |
| WO2019035952A1 (en) * | 2017-08-15 | 2019-02-21 | University Of Washington | Particle separation systems and methods |
| CN209276499U (en) * | 2018-10-26 | 2019-08-20 | 新格元(南京)生物科技有限公司 | A kind of micro-fluidic chip for high-throughput isolation microparticle |
-
2019
- 2019-10-24 CN CN201911016382.6A patent/CN110773244B/en active Active
-
2020
- 2020-10-08 KR KR1020200130419A patent/KR102249533B1/en active IP Right Grant
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN202356108U (en) * | 2011-12-09 | 2012-08-01 | 东南大学 | Micro-current control device for high-throughput separation of nano-grade particles |
| US20180304264A1 (en) * | 2012-10-03 | 2018-10-25 | The Government Of The United States Of America, As Represented By The Secretary Of The Navy | Laser Particle Separation and Characterization with Angled Laser Light to Maximize Residence Time |
| CN105925480A (en) * | 2016-05-12 | 2016-09-07 | 大连理工大学 | Micro-fluidic chip for high-throughput screening of blood brain barrier drug permeability and preparation method of micro-fluidic chip |
| WO2019035952A1 (en) * | 2017-08-15 | 2019-02-21 | University Of Washington | Particle separation systems and methods |
| CN107523481A (en) * | 2017-08-17 | 2017-12-29 | 北京旌准医疗科技有限公司 | A kind of micro-nano biomone screening installation based on micro-fluidic chip |
| CN108499619A (en) * | 2018-03-09 | 2018-09-07 | 复旦大学 | A kind of integrated micro-fluidic filtrating chip of film and its preparation method and application |
| CN209276499U (en) * | 2018-10-26 | 2019-08-20 | 新格元(南京)生物科技有限公司 | A kind of micro-fluidic chip for high-throughput isolation microparticle |
Non-Patent Citations (1)
| Title |
|---|
| 顾月清等: "《生物医学工程技术》", 30 June 2017, 中国医药科技出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115312179A (en) * | 2022-05-27 | 2022-11-08 | 南京欧凯生物科技有限公司 | Single cell screening method for colorectal cancer antibody discovery |
Also Published As
| Publication number | Publication date |
|---|---|
| KR102249533B1 (en) | 2021-05-11 |
| CN110773244B (en) | 2020-10-20 |
| KR20210048990A (en) | 2021-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ko et al. | Tumor spheroid-on-a-chip: a standardized microfluidic culture platform for investigating tumor angiogenesis | |
| US11976294B2 (en) | Hypothermic 3D bioprinting of living tissues supported by perfusable vasculature | |
| Wang et al. | Organ-on-a-chip platforms for drug delivery and cell characterization: A review | |
| CN105925480B (en) | Micro-fluidic chip and preparation method for blood-brain barrier drug permeability high flux screening | |
| CN110773244B (en) | Micro-fluidic chip for high-throughput screening of nano-particles in cross-vascular transport and preparation method thereof | |
| US20110186165A1 (en) | Three-dimensional microfluidic platforms and methods of use and manufacture thereof | |
| US10017724B2 (en) | Engineering of a novel breast tumor microenvironment on a microfluidic chip | |
| Rowe et al. | Active 3-D microscaffold system with fluid perfusion for culturing in vitro neuronal networks | |
| EP3153290B1 (en) | Method of manufacturing mold and method of manufacturing pattern sheet | |
| KR101104305B1 (en) | Fabrication Method of Polymeric Janus Microfiber having Porous Surface for Tissue Engineering | |
| Azizipour et al. | Uniformity of spheroids-on-a-chip by surface treatment of PDMS microfluidic platforms | |
| Fernández‐Costa et al. | Training‐on‐a‐chip: a multi‐organ device to study the effect of muscle exercise on insulin secretion in vitro | |
| CN110257249A (en) | A kind of micro-fluidic chip and administration cultural method for tumour cell dimensional culture | |
| CN105663023A (en) | Method for preparing light-control medicine releasing micro-needles | |
| CN107362844A (en) | Micro-fluidic chip of 3D solid knurl model based on administration nano-drug administration system screening and its preparation method and application | |
| KR102037595B1 (en) | Hydrogel membrane fixed vertically in microfluidic chip and preparation method thereof | |
| Cabodi et al. | An active wound dressing for controlled convective mass transfer with the wound bed | |
| CN113038978A (en) | Microfluidic gas exchange device and method of manufacturing the same | |
| KR101986016B1 (en) | Trapping tool single cells and its manufacturing method | |
| EP3329906A1 (en) | Method of producing transdermal absorption sheet for medical use | |
| CN103992948B (en) | A kind of micro-nano-fluidic control device for cell migration research | |
| CN112264115B (en) | Fishbone microfluidic chip carrying molecular imprinting inverse opal structure microspheres and preparation method thereof | |
| CN107723305A (en) | It is a kind of for gene transfection in can light field controlling gene quick release method | |
| Martín-Asensio et al. | Recapitulating Solid Stress on Tumor on a Chip for Nanomedicine Diffusive Transport Prediction | |
| Lei | Microfluidic Chip Fabrication for Tumor Cell 3D Culture Based on Microwell Arrays |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CP03 | Change of name, title or address | ||
| CP03 | Change of name, title or address |
Address after: 250353 University Road, Changqing District, Ji'nan, Shandong Province, No. 3501 Patentee after: Qilu University of Technology (Shandong Academy of Sciences) Country or region after: China Address before: 250353 University Road, Changqing District, Ji'nan, Shandong Province, No. 3501 Patentee before: Qilu University of Technology Country or region before: China |